NasdaqCM - Delayed Quote USD

Bellevue Life Sciences Acquisition Corp. (BLACW)

Compare
0.0255
-0.0048
(-15.84%)
At close: January 24 at 4:00:00 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
2,242.3510
1,830.7000
35.3880
3.3080
Operating Income
-2,242.3510
-1,830.7000
-35.3880
-3.3080
Net Non Operating Interest Income Expense
2,144.2950
2,775.2910
--
--
Pretax Income
-98.0560
944.5910
-35.3880
-3.3080
Tax Provision
376.8020
540.8110
--
--
Net Income Common Stockholders
-474.8580
403.7800
-35.3880
-3.3080
Diluted NI Available to Com Stockholders
-474.8580
403.7800
-35.3880
-3.3080
Total Operating Income as Reported
-2,242.3510
-1,830.7000
-35.3880
--
Total Expenses
2,242.3510
1,830.7000
35.3880
3.3080
Net Income from Continuing & Discontinued Operation
-474.8580
403.7800
-35.3880
-3.3080
Normalized Income
-474.8580
403.7800
-35.3880
-3.3080
Interest Income
2,144.2950
2,775.2910
--
--
Net Interest Income
2,144.2950
2,775.2910
--
--
EBIT
-2,242.3510
-1,830.7000
-35.3880
-3.3080
EBITDA
-2,242.3510
-1,830.7000
-35.3880
-3.3080
Net Income from Continuing Operation Net Minority Interest
-474.8580
403.7800
-35.3880
-3.3080
Normalized EBITDA
-2,242.3510
-1,830.7000
-35.3880
-3.3080
Tax Rate for Calcs
0.0002
0.0002
--
--
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers